International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Trial ID or NCT#

NCT02844517

Status

not recruiting iconNOT RECRUITING

Purpose

The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named inControl and the inControl Cloud and assess 24/7 in-home usability prior to initiating a large randomized controlled trial.

Official Title

Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial Research Site Training Protocol

Eligibility Criteria

Ages Eligible for Study: 14 Years to 74 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Bruce Buckingham
Bruce Buckingham
Endocrinologist
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus

Contact us to find out if this trial is right for you.

Contact

Bruce Buckingham, MD
650-723-5791